Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Orchestra BioMed Holdings (OBIO) Invested Capital (2022 - 2025)

Historic Invested Capital for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $43.7 million.

  • Orchestra BioMed Holdings' Invested Capital fell 536.58% to $43.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $43.7 million, marking a year-over-year decrease of 536.58%. This contributed to the annual value of $33.0 million for FY2024, which is 5156.3% down from last year.
  • Latest data reveals that Orchestra BioMed Holdings reported Invested Capital of $43.7 million as of Q3 2025, which was down 536.58% from $295000.0 recorded in Q2 2025.
  • In the past 5 years, Orchestra BioMed Holdings' Invested Capital ranged from a high of $99.8 million in Q1 2023 and a low of -$6.1 million during Q3 2022
  • In the last 4 years, Orchestra BioMed Holdings' Invested Capital had a median value of $44.1 million in 2024 and averaged $41.8 million.
  • Its Invested Capital has fluctuated over the past 5 years, first skyrocketed by 237764.57% in 2023, then crashed by 9933.14% in 2025.
  • Over the past 4 years, Orchestra BioMed Holdings' Invested Capital (Quarter) stood at $54.6 million in 2022, then grew by 24.57% to $68.0 million in 2023, then tumbled by 51.56% to $33.0 million in 2024, then soared by 32.71% to $43.7 million in 2025.
  • Its Invested Capital stands at $43.7 million for Q3 2025, versus $295000.0 for Q2 2025 and $16.9 million for Q1 2025.